InvestorsHub Logo
Post# of 64590
Next 10
Followers 9
Posts 920
Boards Moderated 0
Alias Born 04/21/2014

Re: None

Thursday, 12/07/2017 12:12:15 PM

Thursday, December 07, 2017 12:12:15 PM

Post# of 64590
OMHE_Projected_Annual_Rev_to_Increase_by_7Million_to_a_Total_of_$11.3Million

OMHE also developed Marijuana Medicine and applying for FDA Approval


Current Annual Revenue....................=$4.3 Million
Projected Annual Addition..................=$7.0 Million
Total Projected Annual Revenue....=$11.3 Million


12/05/2017 MMJ Medicine Development & FDA Approval and Revenue Add News - Read Here

By employing an FDA regulations-savvy, ‘fast-track’ pipeline strategy, Omni Health will quickly be in a position to partner our new drug for late-phase development,” said Omni Health’s CEO, Andrey Soloviev.



Simultaneous to the FDA application for this new drug, the Company will commence by manufacturing OTC analgesic creams and ointments containing CBD with rapid absorption and optimal bioavailability profiles. Given the potency of these analgesics, they will be marketed and distributed exclusively to doctors’ offices, clinics, and hospitals to ensure appropriate patient support and product usage. As per the current schedule, it’s anticipated they this product will be introduced to the North American market during Q3 2018. Based on current market trends and competitor analysis, Omni Health projects generating a recurring annual revenue exceeding $7 Million.



OMHE PPS Ready to Rise to $1


Made Thousands into Millions..Now in Tens of Millions

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.